A nomogram integrating TO, lymph node metastasis, prothrombin time, and adjuvant therapy demonstrated excellent predictive accuracy for survival (1-year area under the curve = 0.891).<h4>Conclusion</h4>Achieving TO is associated with significantly improved survival in patients with ICC. The gene discussed is F2; the disease is intrahepatic cholangiocarcinoma.